Back to Market Feed

Historical record - last NADAC effective date: 6/15/2016

Product Information

RIBAVIRIN 200 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $1.2755 per EA under NDC 65862029018. Its NADAC has been published 186 times since Nov 28, 2013.

FDA first approved this application on Sep 17, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIBAVIRIN 200 MG CAPSULE

Ribavirin
$1.2755per EA

Strength

200 mg/1

NDC

65862029018

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

6/15/2016

Active Ingredients

RIBAVIRIN

Approval Type

Generic (ANDA)

FDA Application

ANDA079117

FDA Approved

9/17/2009

TE Code

AB

On Market Since

9/17/2009

Pharmacological Classes

Nucleoside Analog Antiviral
Nucleoside Analog

Price Statistics

The NADAC for RIBAVIRIN 200 MG CAPSULE has been published 186 times since Nov 28, 2013, and over the history we have for it it has risen 73.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2755 per EA
All-time high$2.2763 (Mar 12, 2014)
All-time low$0.4723 (Apr 23, 2014)
Median price$0.8732
Average price$1.0048
Largest weekly change+209.4% (Jan 22, 2014)
Weeks tracked186
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+73.4%

Last surveyed Jun 14, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ribavirin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

ACYCLOVIR 200 MG/5 ML SUSP
Generic
00472008216•Actavis Pharma, Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
31722068147•Camber Pharmaceuticals Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
62135080347•Chartwell RX LLC
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
70954018810•ANI Pharmaceuticals, Inc.
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72205017072•Novadoz Pharmaceuticals LLC
$0.0694
per ML
ACYCLOVIR 200 MG/5 ML SUSP
Generic
72888007917•Advagen Pharma Ltd.
$0.0694
per ML
ACYCLOVIR 400 MG TABLET
Generic
75834012201•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 400 MG TABLET
Generic
75834012205•Nivagen Pharmaceuticals Inc.
$0.0779
per EA
ACYCLOVIR 200 MG CAPSULE
Generic
75834012401•Nivagen Pharmaceuticals Inc.
$0.0971
per EA
ACYCLOVIR 200 MG CAPSULE
Generic
00904578961•Major Pharmaceuticals
$0.0973
per EA

Frequently asked questions

What is the NADAC price of RIBAVIRIN 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIBAVIRIN 200 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $1.2755 per EA (NDC 65862029018), effective Jun 14, 2017.

How has the price of RIBAVIRIN 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIBAVIRIN 200 MG CAPSULE has risen 73.4%. It has been tracked across 186 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RIBAVIRIN 200 MG CAPSULE?

Since Nov 28, 2013, the NADAC for RIBAVIRIN 200 MG CAPSULE has ranged from a low of $0.4723 (Apr 23, 2014) to a high of $2.2763 (Mar 12, 2014), with a median of $0.8732 per EA.

Are there cheaper alternatives to RIBAVIRIN 200 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of RIBAVIRIN 200 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures RIBAVIRIN 200 MG CAPSULE?

RIBAVIRIN 200 MG CAPSULE (NDC 65862029018) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.